Literature DB >> 26867053

Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study.

Lu Yao1, Aaron R Folsom, James S Pankow, Elizabeth Selvin, Erin D Michos, Alvaro Alonso, Weihong Tang, Pamela L Lutsey.   

Abstract

BACKGROUND: Recent evidence suggests that parathyroid hormone (PTH) has effects on vascular smooth muscle cells, the rennin-angiotensin system and kidney function, but less is known about its role in the development of hypertension. The distribution of serum PTH also varies by race. METHODS AND
RESULTS: Therefore, we examined the relation between PTH and incident hypertension and tested for interaction by race among 7504 Atherosclerosis Risk in Communities participants (1264 black, 6240 white, median age 56 years) without initial hypertension in 1990-1992. During a median follow-up of 6 years, 1487 white and 509 black participants developed hypertension. In the overall study population, PTH was not associated with incident hypertension after adjustment for demographics and behavioral risk factors [hazard ratio highest vs. lowest quintiles, 95% confidence interval: 1.11 (0.96-1.28); P for linear trend 0.02]. Although the interaction was not statistically significant (P = 0.60), there was some evidence that the PTH-hypertension association differed by race. Among blacks, PTH was positively associated with incident hypertension, independent of demographics, and behavioral risk factors (P for linear trend 0.003). Among whites, PTH was not associated with hypertension risk. Results were similar when comparing participants with elevated versus nonelevated PTH (≥65 vs. <65 pg/ml): hazard ratio in blacks: 1.24 (1.02-1.54); hazard ratio in whites: 0.95 (0.78-1.16).
CONCLUSIONS: In this large community-based cohort, PTH levels, overall, were not independently associated with the risk of hypertension. However, we found some evidence that PTH may be associated with hypertension in blacks. Future research should continue to explore potential race differences in the PTH-hypertension association.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26867053      PMCID: PMC4755355          DOI: 10.1097/HJH.0000000000000794

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  47 in total

1.  Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?

Authors:  Jeffrey L Anderson; Ryan C Vanwoerkom; Benjamin D Horne; Tami L Bair; Heidi T May; Donald L Lappé; Joseph B Muhlestein
Journal:  Am Heart J       Date:  2011-08       Impact factor: 4.749

2.  Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways.

Authors:  Gloria Rashid; Jacques Bernheim; Janice Green; Sydney Benchetrit
Journal:  Am J Physiol Renal Physiol       Date:  2006-12-26

3.  Resistance to bone resorbing effects of PTH in black women.

Authors:  F Cosman; D C Morgan; J W Nieves; V Shen; M M Luckey; D W Dempster; R Lindsay; M Parisien
Journal:  J Bone Miner Res       Date:  1997-06       Impact factor: 6.741

4.  High parathyroid hormone, but not low vitamin D concentrations, expose elderly inpatients to hypertension.

Authors:  Leyla Mateus-Hamdan; Olivier Beauchet; Béatrice Bouvard; Erick Legrand; Bruno Fantino; Cédric Annweiler
Journal:  Geriatr Gerontol Int       Date:  2012-09-19       Impact factor: 2.730

5.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

6.  Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants.

Authors:  Setor Kwadzo Kunutsor; Tanefa Antoinette Apekey; Marinka Steur
Journal:  Eur J Epidemiol       Date:  2013-03-02       Impact factor: 8.082

Review 7.  Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor?

Authors:  John H Lee; James H O'Keefe; David Bell; Donald D Hensrud; Michael F Holick
Journal:  J Am Coll Cardiol       Date:  2008-12-09       Impact factor: 24.094

8.  Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents.

Authors:  N H Bell; A L Yergey; N E Vieira; M J Oexmann; J R Shary
Journal:  J Bone Miner Res       Date:  1993-09       Impact factor: 6.741

9.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

10.  Parathyroid hormone and the risk of incident hypertension.

Authors:  Eric N Taylor; Gary C Curhan; John P Forman
Journal:  J Hypertens       Date:  2008-07       Impact factor: 4.844

View more
  6 in total

Review 1.  The Parathyroid Gland and Heart Disease.

Authors:  Spandana J Brown; Mary D Ruppe; Laila S Tabatabai
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

2.  Association of bone metabolism markers with coronary atherosclerosis and coronary artery disease in postmenopausal women.

Authors:  Yan Ling; Zhen Wang; Bingjie Wu; Xin Gao
Journal:  J Bone Miner Metab       Date:  2017-06-22       Impact factor: 2.626

Review 3.  Primary hyperparathyroidism and hypertension.

Authors:  Sarah B Fisher; Nancy D Perrier
Journal:  Gland Surg       Date:  2020-02

Review 4.  Use of Biomarkers in the Evaluation and Treatment of Hypertensive Patients.

Authors:  Gemma Currie; Christian Delles
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

5.  Effects of Different Dietary Interventions on Calcitriol, Parathyroid Hormone, Calcium, and Phosphorus: Results from the DASH Trial.

Authors:  Ahmed Hassoon; Erin D Michos; Edgar R Miller; Zeni Crisp; Lawrence J Appel
Journal:  Nutrients       Date:  2018-03-17       Impact factor: 5.717

6.  Targeting the ASMase/S1P pathway protects from sortilin-evoked vascular damage in hypertension.

Authors:  Paola Di Pietro; Albino Carrizzo; Eduardo Sommella; Marco Oliveti; Licia Iacoviello; Augusto Di Castelnuovo; Fausto Acernese; Antonio Damato; Massimiliano De Lucia; Fabrizio Merciai; Paola Iesu; Eleonora Venturini; Raffaele Izzo; Valentina Trimarco; Michele Ciccarelli; Giuseppe Giugliano; Roberto Carnevale; Vittoria Cammisotto; Serena Migliarino; Nicola Virtuoso; Andrea Strianese; Viviana Izzo; Pietro Campiglia; Elena Ciaglia; Bodo Levkau; Annibale A Puca; Carmine Vecchione
Journal:  J Clin Invest       Date:  2022-02-01       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.